Search

Your search keyword '"Zheng, Qiufan"' showing total 5 results
Start Over Author "Zheng, Qiufan" Journal journal of clinical oncology
5 results on '"Zheng, Qiufan"'

1. Neoadjuvant pegylated liposomal doxorubicin-containing chemotherapy in combination with trastuzumab and pertuzumab in patients with HER2-positive early breast cancer: A randomized phase II study (METIS).

Author

Xia, Wen, primary, Yuan, Zhongyu, additional, Wang, Shusen, additional, Zheng, Qiufan, additional, Wu, Zhiyong, additional, Zhong, Muyi, additional, Xu, Fei, additional, Wang, Ying, additional, Ma, Xiaopeng, additional, Ma, Shihui, additional, Zhang, Yuan-Qi, additional, Zhang, Lehong, additional, Shi, Yanxia, additional, Huang, Heng, additional, Xu, Xiangdong, additional, and Li, Haiyan, additional

Published
2024
Full Text
View/download PDF

2. Efficacy and safety of pegfilgrastim in prophylaxis of chemotherapy-induced neutropenia in breast cancer patients.

Author

Xia, Wen, primary, Xu, Fei, additional, Yuan, Zhongyu, additional, Xu, Ruilian, additional, Jiang, Yi, additional, Wu, Zhiyong, additional, Lu, Qianyi, additional, Zheng, Qiufan, additional, Hong, Ruoxi, additional, Jiang, Kuikui, additional, Huang, Jiajia, additional, An, Xin, additional, Bi, XiWen, additional, Hong, Yun, additional, Pang, Danmei, additional, Zhang, Anqin, additional, Wang, Xianming, additional, Zhang, Qing, additional, Zhang, Haibo, additional, and Wang, Shusen, additional

Published
2020
Full Text
View/download PDF

3. Fulvestrant as maintenance therapy after first-line chemotherapy in patients with hormone receptor-positive, HER2-negative advanced breast cancer (FANCY), a prospective, multicenter, single arm phase 2 study.

Author

Wang, Shusen, primary, Zheng, Qiufan, additional, Xu, Fei, additional, Xia, Wen, additional, Ouyang, Quchang, additional, Pang, Danmei, additional, Yuan, Huimin, additional, Shi, Yanxia, additional, Peng, Roujun, additional, and Yuan, Zhongyu, additional

Published
2017
Full Text
View/download PDF

5. Fulvestrant as maintenance therapy after first-line chemotherapy in postmenopausal hormone receptor-positive, HER2-negative advanced breast cancer patients (FANCY): A prospective, multicenter, single arm phase II study.

Author

Wang, Shusen, primary, Xu, Fei, additional, Ouyang, Quchang, additional, Yuan, Zhongyu, additional, Pang, Danmei, additional, Yuan, Huimin, additional, Peng, Roujun, additional, Xia, Wen, additional, and Zheng, Qiufan, additional

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results